GLP-1 Medications: Could Weight Loss Treatments Actually Increase Dementia Risk?
New findings suggest GLP-1 medications may elevate dementia risk, challenging existing beliefs about obesity treatments.
Eli Lilly
New Studies Reveal GLP-1 Drugs May Alter Dementia Risk—What You Need to Know
GLP-1 drugs may reduce dementia risk by 30%. Find out how these medications influence cognitive health and what this means for prevention.